DexCom received a warning letter from the Food and Drug Administration following inspections of its San Diego and Mesa, Ariz.

Shares of DexCom Inc. rallied 3.79% to $73.38 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 1.08% to 5,675.29 and the Dow ...

Medical device companies presented new data this week at the Advanced Technologies & Treatments for Diabetes conference.

DexCom, Inc. (NASDAQ: DXCM), a global leader in glucose biosensing, today announced the launch of its first multi-region report, the "Dexcom State of Type 2 Report: Access and Attitudes Across Europe ...

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...

DexCom Inc. closed 51.77% below its 52-week high of $142.00, which the company achieved on March 26th.

Wells Fargo analyst Larry Biegelsen maintained a Buy rating on Dexcom (DXCM – Research Report) yesterday and set a price target of $98.00. The ...

PNC Financial Services Group Inc. raised its position in DexCom, Inc. (NASDAQ:DXCM – Free Report) by 21.5% in the fourth ...

Anticipated earnings release is in 41 days. Professional Analyst Ratings for DexCom In the last month, 3 experts released ratings on this stock with an average target price of $96.33. Unusual ...